Clinical characteristics affecting the outcome of liver retransplantation

被引:74
作者
Wong, T
Devlin, J
Rolando, N
Heaton, N
Williams, R
机构
[1] Institute of Liver Studies, King's College Hospital
[2] c/o Editorial Assistant, Institute of Liver Studies, King's College Hospital, London SE5 9RS, Denmark Hill
关键词
D O I
10.1097/00007890-199709270-00015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The outcome of retransplantation remains unsatisfactory when compared with primary transplantation of the liver, The aim of the present study tvas to determine which preoperative clinical and laboratory risk variables are implicated in the poorer outcome. Methods. The preoperative status of 70 retransplanted patients was compared with a group of 303 time-matched recipients receiving their first graft. Results. Survival. at 1 year was reduced in the retransplant versus the primary transplant group (50% vs, 80%, P<0.001). Preoperatively older age, high United Network of Organ Sharing score, inpatient status, elevated bilirubin, and creatinine levels were associated with increased mortality after a second transplant. Preoperatively, the retransplant group had higher encephalopathy grades, were more likely to he inpatients, and had higher serum creatinine, bilirubin, and white cell levels than the primary recipients (P<0.05 in all cases). The median length of inpatient stay was longer after the second transplant (25 vs. 19 days, P<0.001). Conclusions. These factors assist in the stratification of patients awaiting retransplantation; however, the outcome of this procedure is only likely to be improved with an earlier identification of the patients whet require it, along with an increased priority in organ allocation.
引用
收藏
页码:878 / 882
页数:5
相关论文
共 15 条
[1]  
BALIGA P, 1992, SURGERY, V112, P704
[2]  
BELLE SH, 1993, TRANSPLANT P, V25, P1137
[3]  
CLEMENTS WDB, 1993, ARCH SURG-CHICAGO, V128, P200
[4]   RETRANSPLANTATION IN HEPATITIS-B - A MULTICENTER EXPERIENCE [J].
CRIPPIN, J ;
FOSTER, B ;
CARLEN, S ;
BORCICH, A ;
BODENHEIMER, H .
TRANSPLANTATION, 1994, 57 (06) :823-826
[5]   PROGNOSTIC VALUE OF PREOPERATIVELY OBTAINED CLINICAL AND LABORATORY DATA IN PREDICTING SURVIVAL FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION [J].
CUERVASMONS, V ;
MILLAN, I ;
GAVALER, JS ;
STARZL, TE ;
VANTHIEL, DH .
HEPATOLOGY, 1986, 6 (05) :922-927
[6]   RETRANSPLANTATION OF THE LIVER - A 7-YEAR EXPERIENCE [J].
DALESSANDRO, AM ;
PLOEG, RJ ;
KNECHTLE, SJ ;
PIRSCH, JD ;
STEGALL, MD ;
HOFFMANN, R ;
SOLLINGER, HW ;
BELZER, FO ;
KALAYOGLU, M .
TRANSPLANTATION, 1993, 55 (05) :1083-1087
[7]   Hepatic retransplantation - An analysis of risk factors associated with outcome [J].
Doyle, HR ;
Morelli, F ;
McMichael, J ;
Doria, C ;
Aldrighetti, L ;
Starzl, TE ;
Marino, IR .
TRANSPLANTATION, 1996, 61 (10) :1499-1505
[8]   TRANSPLANTATION IN THE NINETIES [J].
FIRST, MR .
TRANSPLANTATION, 1992, 53 (01) :1-11
[9]   HOST DEFENSES AND IMMUNOLOGICAL ALTERATIONS ASSOCIATED WITH CHRONIC-HEMODIALYSIS [J].
GOLDBLUM, SE ;
REED, WP .
ANNALS OF INTERNAL MEDICINE, 1980, 93 (04) :597-613
[10]   IMPAIRED CELLULAR IMMUNE-RESPONSES IN CHRONIC-RENAL-FAILURE - EVIDENCE FOR A T-CELL DEFECT [J].
KURZ, P ;
KOHLER, H ;
MEUER, S ;
HUTTEROTH, T ;
MEYER, KH ;
BUSCHENFELDE, Z .
KIDNEY INTERNATIONAL, 1986, 29 (06) :1209-1214